154 related articles for article (PubMed ID: 6408071)
1. Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils.
Chilton FH; O'Flaherty JT; Ellis JM; Swendsen CL; Wykle RL
J Biol Chem; 1983 Jun; 258(12):7268-71. PubMed ID: 6408071
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes.
Ramesha CS; Pickett WC
J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991
[TBL] [Abstract][Full Text] [Related]
3. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.
Chilton FH; Ellis JM; Olson SC; Wykle RL
J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535
[TBL] [Abstract][Full Text] [Related]
4. Metabolic fate of platelet-activating factor in neutrophils.
Chilton FH; O'Flaherty JT; Ellis JM; Swendsen CL; Wykle RL
J Biol Chem; 1983 May; 258(10):6357-61. PubMed ID: 6853486
[TBL] [Abstract][Full Text] [Related]
5. Conversion of 1-O-[3H]alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils.
Venable ME; Nieto ML; Schmitt JD; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18691-8. PubMed ID: 1917993
[TBL] [Abstract][Full Text] [Related]
6. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
7. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product.
Malone B; Lee T; Snyder F
J Biol Chem; 1985 Feb; 260(3):1531-4. PubMed ID: 3918041
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation.
Venable ME; Olson SC; Nieto ML; Wykle RL
J Biol Chem; 1993 Apr; 268(11):7965-75. PubMed ID: 8463317
[TBL] [Abstract][Full Text] [Related]
10. Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18).
Triggiani M; Chilton FH
Biochim Biophys Acta; 1989 Nov; 1006(1):41-51. PubMed ID: 2572273
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human promyelocytic leukemic HL60 cells. Stimulated expression of phospholipase A2 and acetyltransferase requires differentiation.
Billah MM; Eckel S; Myers RF; Siegel MI
J Biol Chem; 1986 May; 261(13):5824-31. PubMed ID: 3084473
[TBL] [Abstract][Full Text] [Related]
12. Acylation of lysophospholipids by rabbit alveolar macrophages. Specificities of CoA-dependent and CoA-independent reactions.
Robinson M; Blank ML; Snyder F
J Biol Chem; 1985 Jul; 260(13):7889-95. PubMed ID: 4008481
[TBL] [Abstract][Full Text] [Related]
13. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
15. Reacylation of platelet activating factor with eicosapentaenoic acid in fish-oil-enriched monkey neutrophils.
Chabot MC; Schmitt JD; Bullock BC; Wykle RL
Biochim Biophys Acta; 1987 Nov; 922(2):214-20. PubMed ID: 2823907
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil.
Triggiani M; D'Souza DM; Chilton FH
J Biol Chem; 1991 Apr; 266(11):6928-35. PubMed ID: 2016306
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of arachidonic acid into 1-acyl-2-lyso-sn-glycero-3-phosphocholine of the human neutrophil.
Chilton FH; Hadley JS; Murphy RC
Biochim Biophys Acta; 1987 Jan; 917(1):48-56. PubMed ID: 3098298
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
19. 1-O-alkyl-linked glycerophospholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species.
Mueller HW; O'Flaherty JT; Greene DG; Samuel MP; Wykle RL
J Lipid Res; 1984 Apr; 25(4):383-8. PubMed ID: 6427378
[TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells.
Botitsi E; Mavri-Vavayanni M; Siafaka-Kapadai A
J Lipid Res; 1998 Jun; 39(6):1295-304. PubMed ID: 9643362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
